Corcept Therapeutics Inc’s recent filing unveils that its Chief Development Officer Guyer William unloaded Company’s shares for reported $0.7 million on Jan 06 ’26. In the deal valued at $35.18 per share,20,000 shares were sold. As a result of this transaction, Guyer William now holds 1,235 shares worth roughly $44892.25.
Then, Guyer William bought 20,000 shares, generating $699,000 in total proceeds.
Before that, Guyer William sold 20,000 shares. Corcept Therapeutics Inc shares valued at $1,601,526 were divested by the Chief Development Officer at a price of $80.08 per share. As a result of the transaction, Guyer William now holds 1,235 shares, worth roughly $44892.25.
Wolfe Research downgraded its Corcept Therapeutics Inc [CORT] rating to an Underperform from a a Peer perform in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in mid December with a ‘”a Neutral”‘ rating. Wolfe Research began covering CORT with “Peer perform” recommendation on November 18, 2025. Truist revised its rating on November 06, 2023. It rated CORT as “a Buy” which previously was an “a Hold”.
Price Performance Review of CORT
On Tuesday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock fall -2.70% to $36.35. Over the last five days, the stock has gained 1.59%. Corcept Therapeutics Inc shares have fallen nearly -27.08% since the year began. Nevertheless, the stocks have risen 4.45% over the past one year.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2025-12-31, dropping by -1.19 million shares to a total of 9.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 10.34 million shares. There was a decline of -13.05%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 11, 2023 when SVB Securities began covering the stock and recommended ‘”a Market perform”‘ rating along with a $25 price target.
